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a b s t r a c t
In vertebrates, BMP signaling has been demonstrated to be sufﬁcient for bone formation in several tissue
contexts. This suggests that genes necessary for bone formation are expressed in a BMP signaling
dependent manner. However, till date no gene has been reported to be expressed in a BMP signaling
dependent manner in bone. Our aim was to identify such genes. On searching the literature we found
that several microarray experiments have been conducted where the transcriptome of osteogenic cells in
absence and presence of BMP signaling activation have been compared. However, till date, there is no
evidence to suggest that any of the genes found to be upregulated in presence of BMP signaling in these
microarray analyses is indeed a target of BMP signaling in bone. We wanted to utilize this publicly
available information to identify candidate BMP signaling target genes in vivo. We performed a meta-
analysis of six such comparable microarray datasets. This analysis and subsequent experiments led to the
identiﬁcation of ﬁve targets of BMP signaling in bone that are conserved both in mouse and chick. Of
these Lox, Klf10 and Gpr97 are likely to be direct transcriptional targets of BMP signaling pathway. Dpysl3,
is a novel BMP signaling target identiﬁed in our study. Our data demonstrate that Dpysl3 is important for
osteogenic differentiation of mesenchymal cells and is involved in cell secretion. We have demonstrated
that the expression of Dpysl3 is co-operatively regulated by BMP signaling and Runx2. Based on our
experimental data, in silico analysis of the putative promoter-enhancer regions of Bmp target genes and
existing literature, we hypothesize that BMP signaling collaborates with multiple signaling pathways to
regulate the expression of a unique set of genes involved in endochondral ossiﬁcation.
& 2014 Published by Elsevier Inc.
Introduction
In developing embryos, long bones are formed by endochondral
ossiﬁcation (Erlebacher et al., 1995). Based on experiments involving
implantation of decalciﬁed bone (Urist, 1965) and loss of function
studies in mice (Bandyopadhyay et al., 2006), it is now known that
BMP signaling is a critical regulator of endochondral bone formation.
To develop a comprehensive molecular understanding of osteogen-
esis, downstream of BMP signaling, it is necessary to identify the
genes that are expressed in a BMP signaling dependent manner in
developing bone. Recently, a set of Bmp4 induced genes were
identiﬁed in developing cranial bones (Bonilla-Claudio et al., 2012),
which are formed as a result of intramembranous ossiﬁcation.
However, till date, no such transcriptional target of BMP signaling
has been identiﬁed in developing endochondral bone.
Our objective was to identify in vivo targets of BMP signaling in
bone. One approach for identifying candidate BMP signaling target
genes in developing long bones would be through microarray
analysis of osteogenic cells where BMP signaling has been
manipulated. However, to ensure that the candidate genes identi-
ﬁed through such experiments are indeed expressed in the
developing long bones in response to BMP signaling, it would be
necessary to examine the Bmp dependence of their expression
in vivo.
Several different cell lines are used as model systems to study
osteogenesis in vitro. C2C12, a mouse myoblast cell line, and bone
marrow stromal cells (BMSCs) are the two most commonly used
cell types for this purpose (Beresford, 1989; Yaffe and Saxel, 1977).
To analyze the transcriptomic changes upon manipulation of BMP
signaling in C2C12 or BMSC cells, cultured under osteogenic
conditions, several microarray experiments were conducted with
the aim of identifying candidate BMP signaling target genes during
osteogenesis (Balint et al., 2003; de Jong et al., 2004, 2002;
Korchynskyi et al., 2003; Locklin et al., 2001; Vaes et al., 2002).
Although many transcripts were found to be upregulated follow-
ing activation of BMP signaling in each of these experiments, till
date none of these genes have been reported to be expressed in a
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Bmp dependent manner in developing long bones. Nonetheless,
the genes found to be upregulated upon activation of BMP
signaling in any of these experiments are good candidate Bmp
target genes in developing long bones.
A quick manual examination reveals that there was very little
overlap between these different experiments. Thus to identify
in vivo BMP signaling targets using these datasets one would need
to conduct a very large scale expression screen for all such
candidate genes (a total of 800BMP dependent genes were
identiﬁed in these studies) identiﬁed in any of these studies using
wild type and BMP signaling deﬁcient developing bones. We
decided to use these existing datasets as the starting point for
identiﬁcation of transcriptional targets of BMP signaling in devel-
oping long bones. In order to minimize the number of genes to be
screened and maximize the probability of identifying BMP signal-
ing targets that are relevant in vivo, we decided to carry out meta-
analysis of these six microarray experiments, having similar
experimental design and conducted under similar conditions
(Balint et al., 2003; de Jong et al., 2004, 2002; Korchynskyi et al.,
2003; Locklin et al., 2001; Vaes et al., 2002). Through this analysis,
we identiﬁed 14 genes whose expression levels were found to be
up-regulated in at least three of the six microarray experiments.
Using two different mouse models, we have demonstrated that
seven of these 14 candidate genes are expressed in developing
long bones in a BMP signaling dependent manner. The putative
BMP signaling target genes identiﬁed in this study are, Dihydro-
pyrimidinase like-3 (Dpysl3), G protein-coupled receptor 97 (Gpr97),
Kruppel-like factor 10 (Klf10), Lysyl oxidase (Lox), Gap junction
protein, alpha 1 (Gja1), Aspartyl amino peptidase (Dnpep) and
Periostin (Osf2). Through knock-down studies in chicken, we have
demonstrated that ﬁve (Dpysl3, Gpr97, Klf10, Lox, Gja1, Dnpep and
Osf2 ) of these seven genes are targets of BMP signaling in
developing long bones in mouse as well as chick. While the
in vivo experiments demonstrate that the expression of Gpr97,
Lox, Osf2, Dpysl3, Gja1, Dnpep and Klf10 in developing long bones is
dependent on BMP signaling, it is difﬁcult to predict from these
experiments whether these are direct or indirect targets of BMP
signaling. Thus we conducted cell culture based experiments
which suggested that Gpr97, Lox and Klf10 are direct targets of
BMP signaling while expression of Dpysl3 is dependent on both
BMP signaling as well as Runx2 activity. Further, through knock-
down experiments, using chicken and mouse cell culture systems,
we have demonstrated that Dpysl3 is involved in cell secretion and
osteogenic differentiation. The transcriptional targets of BMP
signaling identiﬁed in this study should help in developing a
comprehensive molecular understanding of BMP signaling leading
to long bone formation.
Materials and methods
Mouse strains
Bmp2C/C; Bmp4C/C; Prx1::Cre, henceforth referred to as Bmp2/4
DCKO (Bandyopadhyay et al., 2006) and Bmp2C/C; Bmp4C/C;
R26CreER/R26CreER, henceforth referred to as Bmp2/4 TiDCKO
(Yadav et al., 2012) mouse strains have been described previously.
All animal experiments were conducted according to the
protocol approved by the Institute Animal Ethics Committee
(IAEC) of Indian Institute of Technology Kanpur, India, which is
registered with the Committee for the Purpose of Supervision and
Control of Experiments on Animals (CPCSEA), Ministry of Environ-
ment and Forests, Government of India (reg. no. 810/03/ac/
CPCSEA, dated 15/10/2003).
Chick eggs and embryos
Fertilized white leghorn chicken eggs were procured from the
following sources: (1) U.P. Government Poultry Farm, Chak
Gazaria, U.P., India, (2) Central Avian Research Institute, Bareilly,
U.P., India, (3) Chandra Shekhar Azad University of Agriculture &
Technology, Kanpur and (4) Santosh's poultry farm, Nankari
village, Kanpur, U.P., India.
The eggs were incubated at 38 1C in a humidiﬁed incubator
until the embryos attained the desired stage. Embryos were staged
in accordance with Hamburger and Hamilton (Hamburger and
Hamilton, 1992).
Tamoxifen inducible conditional depletion of Bmp2 and Bmp4 and
genotyping
Bmp2C/C; Bmp4C/C; R26CreER/þ animals were crossed. Single injec-
tion of tamoxifen (Sigma-Aldrich, USA, 2.5 mg/20 g body weight) was
administered to pregnant females at 14.5 dpc and embryos were
harvested at 16.5 dpc for further analysis. The efﬁciency of recombina-
tion was evaluated using a set of genotyping primers (see below) and
the reduction in Bmp signaling was evaluated by anti-p-Smad1/5/8
immunoreactivity (see below). Primer pairs for genotyping of ﬂoxed
Bmp2 and Bmp4 loci have been described earlier (Bandyopadhyay
et al., 2006). The primer pairs used for genotyping Rosa26CreER
locus have been described earlier (Soriano, 1999). For evaluating
Cre-mediated recombination the primers, AB457, AB440, AB458 and
AB299 were used. AB457, 50-GGCAGACATTGTATCTCTAGG-30 and
AB440, 50-AGGGTGCAGGCAGGAAACAT yielded a 400 bp product for
the recombined Bmp2 locus while AB458, 50-AGACTCTTTAGTGAG-
CATTTTCAAC and AB299, 50-AGGTGAGCAGAGCTAAGATG yielded a
500 bp product for the recombined Bmp4 locus. For a map of
corresponding genomic regions and primer locations please refer to
(Yadav et al., 2012).
Preparation of knockdown construct
The avian retroviral vector RCASBP(A) (Greenhouse et al., 1988)
was used to deliver miRNA based knockdown sequences speciﬁcally
targeting chicken Bmp2 and Bmp4mRNAs. miRNA targeting the
coding regions of chicken Bmp2 and Bmp4 were designed using the
BLOCK-iT RNAi Designer (Invitrogen). In brief, four pairs of oligos
containing miRNA target sites, two each targeting chicken Bmp2 and
Bmp4mRNAs, were cloned into the pRmiR shuttle vector (Smith et al.,
2009a) separately (Table S3). Subsequently, all the four miRNA based
hairpins were concatamerized into one shuttle vector, thus forming a
chain of hairpins targeting chicken Bmp2 and Bmp4mRNAs. This
construct is named as pRmiR-gga-mirBmp2/mirBmp4. This cassette of
four hairpins was then sub-cloned into the ClaI site of RCASBP
(A) avian retroviral vector to generate Bmp2/Bmp4 double knock-
down virus, henceforth referred to as RCASBP(A)-gga-mirBmp2/
mirBmp4. Virus particles were produced in chicken DF1 cells
(Himly et al., 1998), collected and concentrated as described pre-
viously (Logan and Tabin, 1998). The efﬁciency of knockdown was
veriﬁed by infecting DF-1 cells with RCASBP(A)-gga-mirBmp2/
mirBmp4 for ﬁve days followed by semi-quantitative RT-PCR using
primers (Table S3) speciﬁc for chicken Bmp2 and Bmp4 genes. miRNA
sequence targeting LacZ (Invitrogen) was used as the negative
control. Hamburger and Hamilton (1992) stage18 (HH18) limb buds
of white leghorn chicken embryos were infected with concentrated
virus particles as previously reported (Logan and Tabin, 1998; Smith
et al., 2009b). The knockdown constructs for targeting chicken
(Accession no. NM_204493) and mouse Dpysl3 (Accession no.
NM_009468) genes were prepared following a similar strategy. The
primers used are described in Table S3. Three different knockdown
sequences against chicken (pRmiR-gga-mirDpysl3 [1–3]) and mouse
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(pRmiR-mmu-mirDpysl3 [1–3]) Dpysl3 genes were evaluated for their
knockdown efﬁciency using sensor assays. In brief, knockdown
efﬁciency of miRNA against mouse Dpysl3 was veriﬁed by co-
transfecting pRmiR-mmu-mirDpysl3 [1–3], pcDNA3.1-FFLuc-mmu-
Dpysl3 sensor (where ﬁreﬂy luciferase genes was cloned upstream
of mouse Dpysl3 coding region in pcDNA3.1 vector) and pGL4.74
(expressing renilla luciferase, Promega) into C2C12 cells. Down-
regulation of ﬁreﬂy luciferase activity 24 h post-transfection was
measured. Dual luciferase assay was carried out as per manufac-
turer's recommendations (Promega). Normalized ﬁreﬂy luciferase
activity (with respect to renilla luciferase activity) values from two
independent experiments conducted in triplicates were used for
plotting the graph (Fig. S2C). The miRNA construct demonstrating the
best knockdown efﬁciency was cloned in RCAS vector as described
above and is named as RCASBP(A)-mmu-mirDpysl3.
Similarly, miRNA target regions for chicken Dpysl3 genes were
cloned in pCAG-mCherry expression vector downstream of the
coding sequence of mCherry (pCAG-mCherry-gga-Dpysl3 sensor)
and were co-transfected with pRmiR-gga-mirDpysl3 [1–3] into
HEK293T cells. The ratio of mCherry to GFP (pRmiR vector
expresses GFP protein) was analyzed for knockdown efﬁciency
and the miRNA with maximum knockdown efﬁciency was chosen
for downstream applications. The construct targeting chicken
Dpysl3 is named as pRmiR-gga-mirDpysl3.
Immunohistochemistry
Wild type and mutant/infected limbs of 16.5 dpc mouse embryos/
HH38 chick embryos were ﬁxed in 4% paraformaldehyde, embedded
in parafﬁn, sectioned and stained with anti-p-Smad1/5/8 primary
antibody (Cell Signaling, U.S.A.) for 16 h at 4 1C followed by incuba-
tion with Cy3-conjugated anti-rabbit IgG (Jackson Immunoresearch,
U.S.A.) in PBS for 2 h at room temperature. After washing with PBS,
sections were counterstained with DAPI and mounted in Vectashield
antifade reagent (Vector Laboratories, U.S.A.). For detection of viral
infection 3c2 monoclonal antibody immunoreactivity was tested
following the protocol described previously (Chen and Cepko, 2002).
RNA in situ hybridization
Bmp2/4 DCKO strain—Bmp2C/þ; Bmp4C/þ; Prx1::Cre males were
crossed with Bmp2C/C; Bmp4C/C females. Embryos were harvested
at 16.5 dpc. Following genotyping, hind limbs from Bmp2/4 DCKO
embryos as well as littermate wild type (without the Cre trans-
gene) embryos were collected for further analysis.
Bmp2/4 TiDCKO strain—Tamoxifen induced Bmp2/4 double
conditional knockout mouse embryos were generated as described
above. Embryos were harvested at 16.5 dpc. Following genotyping,
hind limbs from Bmp2/4 TiDCKO embryos as well as littermate
wild type (without the Rosa26CreER locus) embryos were collected
for further analysis.
Bmp2/Bmp4 double knockdown—HH18 embryonic chicken
hind limb buds were infected with RCASBP(A)-gga-mirBmp2/
mirBmp4. Expression of EmGFP protein encoded by RCASBP(A)-
gga-mirBmp2/mirBmp4 was used to identify the tissue infected
with this virus. Infected hind limbs exhibiting extensive EmGFP
expression were harvested at HH38 for further analysis. Unin-
fected contra-lateral limbs were used as controls.
Harvested tissues were embedded in parafﬁn following the
existing protocol (Bandyopadhyay et al., 2006). 5 μm thick serial
sections were generated from parafﬁn embedded wild type and
mutant limbs of 16.5 dpc mouse embryos and infected limbs of HH38
chick embryos. To minimize experimental variables, sections from
the test animal and the corresponding control animal were collected
on the same slide and RNA in situ hybridization was performed as
described before (Bandyopadhyay et al., 2008). The progress of signal
development was monitored continuously and the reactions were
stopped as soon as the signal could be optimally detected in the
control samples. Fragments of cDNAs for each of the mouse genes
(Gpr97, Lox, Dpysl3, Klf10, Dnpep, Gja1, Lxn, Hey1, F3, Pltp, Ugp2, Pedf,
Id3, Eps8 and Lamb3) and chicken genes (Osf2, Klf10 and Gpr97) were
ampliﬁed through RT-PCR and cloned in TA vector (Fermentas).
Primer sequences, complete names of the genes and unigene
numbers are provided in Table S3. The cDNA sequences were veriﬁed
by sequencing and subsequently were used to generate antisense
RNA probes for RNA in situ hybridization. EST clones for chicken Lox
(ChEST374f21) and Dpysl3 (ChEST644l10) from MRC Geneservice
(now known as Source Bioscience—http://www.lifesciences.source-
bioscience.com/), EST clones for mouse Dcn (Clone ID 5028078), Lum
(Clone ID 3585672) and Ogn (Clone ID 5067073) from Invitrogen
(now available through Source Bioscience) and an EST clone for
mouse Osf2 from ATCC (Number 10324734) were used to generate
antisense RNA probes. Other RNA probes have been described
previously: Runx2 (Ducy et al., 1997), Col1a1 (Bernard et al., 1983)
and Bsp (Oldberg et al., 1986). All RNA in situ hybridization experi-
ments were repeated three times with different batches of animals.
Semi-quantitative RT-PCR
C2C12 cells were cultured in DMEMþ10% FBS. 24 h later cells
were transferred to DMEM media containing 0.1% FBS. Six hours
later cycloheximide (10 μg/ml) was added to the cultures and the
cells were grown for another 2 h. Media was replaced and fresh
media (containing 0.1% FBS) containing recombinant Bmp2
(200 ng/ml, Sino Biologicals, China) was added with and without
cycloheximide for 3 h. Total RNA was isolated from cells using
TRIzol reagents (Invitrogen). Reverse transcription was performed
with 5 μg RNA using ImProm-II™ Reverse Transcription System
(Promega U.S.A.). Speciﬁc primers for the RT-PCR of mouse Lox,
Klf10, Gpr97 and Gapdh genes are described in Table S3. Numbers
of PCR cycles employed are: 25 for Lox, 27 for Klf10 and 32 for
Gpr97. The PCR products were analyzed by ethidium bromide
stained agarose gel electrophoresis. The abundance of Gapdh
mRNA did not change signiﬁcantly between experimental condi-
tions. Thus a representative sample for 25 cycles is presented as
control.
Osteogenic differentiation of avianized BMSCs
For osteogenic differentiation, avianized mouse BMSCs (to be
described elsewhere), expressing avian TV-A receptor (Rhim et al.,
1985), were infected with RCASBP(A)-mmu-mirDpysl3 virus and
cultured in osteogenic medium (DMEM, FBS 10%, 50 μg/ml ascor-
bic acid and 10 mM β-glycerophosphate) in presence of Bmp2
protein (100 ng/ml). Media was changed every 3 days. RCASBP(A)-
mirLacZ virus was used as negative control. After 14 days, cells
infected with test and control viruses were quantitatively com-
pared on the basis of the abundance of alkaline phosphatase (ALP)
activity. Also, cells were stained using standard cytological tech-
niques to detect ALP as well as deposition of mineralized matrix as
judged by Alizarin Red and von Kossa staining (Yadav et al., 2012).
Assay for detecting secretion using secreted Gaussia luciferase (Gluc)
DF-1 cells were grown in DMEMþ10% FBS. DF-1 cells were
transfected with pCSCW-Gluc-IRES-GFP and pGL4.74 (expressing
renilla luciferase, Promega) as well as a combination of empty pRmiR,
pRmiR-gga-mirDpysl3, pcDNA3.1, pcDNA3.1-rno-Dpysl3 (pcDNA3.1
vector expressing rat Dpysl3) and pRmiR-mirLacZ as mentioned.
Where appropriate, 24 h post transfection, cells were serum starved
for 6 h and treated with Bmp2 protein (100 ng/ml, Sino Biologicals,
China) for another four hours in the presence of 0.1% FBS. Secreted
luciferase activity was measured from the culture media as described
in the manufacturer's manual (Nanolight, Pinetop AZ, cat. no. 303)
(Tannous, 2009). Normalized secreted luciferase activity (with respect
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to Renilla luciferase activity) values from three independent experi-
ments were used for plotting the graph.
Dual luciferase assay for putative Dpysl3 promoter–enhancer region
The 1498 nucleotides around mouse Dpysl3 (Accession No.
NM_009468) transcription start site (1422 to þ75) were ampli-
ﬁed from the genomic DNA using the following pair of primers;
AB826, 50-TCCTGCTAGCGCCGTGACTAACCGGAAGCC and AB827, 50-
TCCTAAGCTTCCTCCTCCACTGGCGTTCAC and cloned into
pCRsBlunt vector (Invitrogen, USA). The ampliﬁed region was
subsequently subcloned into pBFIR-Basic vector (Yadav et al., 2012)
in-between NheI and BglII restriction enzyme sites upstream of
ﬁreﬂy luciferase gene. pBFIR also expresses renilla luciferase
(Yadav et al., 2012). This construct is henceforth referred to as
pBFIR-mmu-Dpysl3. Two wells of C2C12 cells were transfected
with pBFIR-mmu-Dpysl3 alone and another two wells of C2C12
cells were transfected with pBFIR-mmu-Dpysl3 along with RCAS
vector expressing chicken Runx2 gene (RCAS-gga-Runx2) using
Lipofectamine-2000 (Invitrogen) following the manufacturer's
protocol. After 24 h the culture medium was changed to DMEM
containing 0.1% FBS. Six hours later, one set of wells of C2C12 cells
(transfected with pBFIR-mmu-Dpysl3 alone or pBFIR-mmu-Dpysl3
plus RCAS-gga-Runx2) were supplemented with 100 ng/ml of
recombinant Bmp2 protein. Three hours later, cells were lysed
and dual luciferase assay was carried out as per manufacturer's
recommendation (Promega). Normalized ﬁreﬂy luciferase activity
(with respect to renilla luciferase activity) values from two
independent experiments conducted in triplicates, were used for
plotting the graph.
RNA isolation and real-time PCR analysis
Two wells of C2C12 cells were transfected with empty RCAS
plasmid and another two wells of C2C12 cells were transfected with
RCAS-gga-Runx2 using Lipofectamine-2000 (Invitrogen) following
manufacturer's protocol. 24 h post-transfection the culture medium
was changed to DMEM containing 0.1% FBS. Six hours later, one set of
wells of C2C12 cells (transfected with empty RCAS plasmid or RCAS-
gga-Runx2) were supplemented with 100 ng/ml of recombinant Bmp2
protein. Three hours later, total RNA was isolated using Trizol reagent
(Sigma Aldrich) and cDNA was synthesized from 1 μg of total RNA
using the ImProm-II™ Reverse Transcription System (Promega)
according to the manufacturer's instructions. Real-time PCR was
carried out using ABI 7500 Real-time PCR system (Applied Biosys-
tems). The reactions (20 μl) contained cDNA, forward and reverse
primers and SYBR GREEN PCR Master Mix (Applied Biosystems). The
ampliﬁcation conditions were 50 1C for 2 min, 95 1C for 15 min,
followed by 40 cycles of denaturation at 95 1C for 15 s and annealing
and extension at 60 1C for 1 min. The following primers were used:
Dpysl3, Forward: 50-CAGCCTGGGAATAGATGGAA-30, Reverse: 50-TT-
CTGGGCAGTGCTAAAGGT-30; β-Tubulin, Forward: 50-TTCAGCTGACC-
CACTCACTG-30, Reverse: 50-AGACAGGGTGGCATTGTAGG-30. All PCR
primers were designed using Primer3 software (http://frodo.wi.mit.
edu/primer3).
Bioinformatic analysis
The mVista (Frazer et al., 2004) program was used to identify
the ECRs in the regions 2 kb upstream of the transcription start
sites of putative Bmp signaling target genes using the mouse
genomic region as base sequence. The ECRs identiﬁed were further
analyzed for the presence of potential transcription factor binding
sites which were conserved between mouse, rat and human
(Alvarez-Rodriguez et al., 2007; Liu et al., 2003; Lu et al., 2012;
Yun-Feng et al., 2010; Zheng et al., 2003).
Statistical analysis
Statistical signiﬁcance was calculated by comparison of two
samples using two-tailed Student's t test. po0.05 was considered
signiﬁcant and p40.05 was considered as non-signiﬁcant. (NZ4).
Results
Identiﬁcation of candidate BMP signaling target genes during
osteogenesis through meta-analysis of publicly available microarray
data
Several microarray experiments with osteogenic cells have
been conducted to identify genes whose mRNA expression is
positively regulated by BMP signaling during osteogenic differen-
tiation (Balint et al., 2003; Clancy et al., 2003; de Jong et al., 2004,
2002; Harris et al., 2003; Harris and Harris, 2001; Korchynskyi
et al., 2003; Locklin et al., 2001; Vaes et al., 2002). It should be
noted that mere detection of increase in abundance of a transcript
in cultured cells upon activation of BMP signaling does not
necessarily prove that such a gene is indeed a target in vivo. To
demonstrate that a gene is transcribed in the developing long
bone in a BMP signaling dependent manner it would be necessary
to compare the expression of this gene in a normal bone with a
bone where BMP signaling has been inactivated. Since the micro-
array analyses, mentioned above, have identiﬁed several hundred
candidate BMP target genes the task of validating all of them
in vivo is extremely challenging. We argued that the probability of
a gene being an in vivo target of BMP signaling might be high if the
same gene has been identiﬁed as a BMP signaling target in several
of these studies. Thus we decided to carry out a meta-analysis of
the datasets obtained from these studies (Balint et al., 2003; de
Jong et al., 2004, 2002; Korchynskyi et al., 2003; Locklin et al.,
2001; Vaes et al., 2002). Five of the six experiments used the same
cell line C2C12, while Locklin et al. used bone marrow stromal cells
(BMSCs). Apart from Korchynski et al., who used constitutively
active type I Bmp receptor misexpression, the others used exo-
genously added Bmp protein to induce gain of function of BMP
signaling. To begin our investigation we analyzed the overlap
between these six microarray datasets through a Venn diagram
(Fig. 1) which revealed that the overlap between the datasets is
not very signiﬁcant. The maximum overlap of datasets was
observed between the ones reported by Balint et al. (containing
143 upregulated genes) and Vaes et al., (containing upregulated
172 genes), which had 30 genes in common. In our analysis, we
could not identify a single gene whose expression was upregulated
in all six experiments. In fact we found only two genes, Gja1 and
Osf2, whose expression was upregulated in four of the six experi-
ments (numbers in red, Fig. 1) and expression of only 12 other
genes was upregulated in three out of these six experiments
(numbers in yellow, Fig. 1). We decided to examine the mRNA
expressions of these 14 genes that were upregulated in three or
more of these microarray experiments (Fig. 1 and Table S1) for
their dependence on BMP signaling in developing long bones.
Evaluating the in vivo dependence on BMP signaling for expression of
putative target genes
It has been demonstrated earlier that in Bmp2/4 DCKO mice,
Prx1::Cre, an early limbmesenchyme speciﬁc Cre (Logan et al., 2002),
recombines the Bmp2 and Bmp4 loci much before the onset of
osteogenesis (Bandyopadhyay et al., 2006). Depletion of Bmp2 and
Bmp4 by Prx1::Cre led to severe bone developmental defects, yet
some osteoblast markers such as Col1a1 were still detectable in the
embryonic long bones derived from these mice (Bandyopadhyay
et al., 2006). Thus one may expect that the expression of other bone
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speciﬁc genes should also be detectable in Bmp2/4 DCKO long bones,
unless their expression is dependent upon BMP signaling. We used
the Bmp2/4 DCKO mice to investigate the change in expression of the
14 candidate BMP signaling target genes (Table S1), obtained through
the meta-analysis of microarray datasets. For this purpose we used
16.5 dpc mouse embryonic femurs, derived from Bmp2/4 DCKO as
well as from littermate control animals. To ensure that the BMP
signaling level in Bmp2/4 DCKO bones is signiﬁcantly reduced, we
tested p-Smad1/5/8 immunoreactivity, which is a readout of BMP
signaling activity, in these bones. The level of p-Smad1/5/8 immu-
noreactivity in 16.5 dpc Bmp2/4 DCKO femur (Fig. 2L) is signiﬁcantly
reduced as compared to that in the femur from the littermate
control (Fig. 2A). Since it was reported earlier that the level of Col1a1
mRNA expression remains unchanged in Bmp2/4 DCKO bones
(Bandyopadhyay et al., 2006), we used Col1a1 as a marker of bone
cells in all our analyses.
Among the 14 candidate genes in our list, the mRNA abundance of
seven genes namely, Dpysl3, Gpr97, Klf10, Lox, Gja1, Dnpep and Osf2
was reduced below detectable levels (compare Fig. 2C–I with Fig. 2N–
T) in Bmp2/4 DCKO femur, while the mRNA expression of the other
seven genes did not change signiﬁcantly (Fig. S1, compare panels B-H
with J-P). As expected, the expression of Col1a1 mRNA remained
unchanged (compare Fig. 2B with Fig. 2M) upon Bmp2 and Bmp4
depletion, demonstrating the presence of bone cells in the mutant
femurs. Based on in vitro studies, Runx2, a transcription factor has
been proposed to be acting downstream of BMP signaling in bone (Lee
et al., 2000; Phimphilai et al., 2006). In agreement with this, we
observed that the expression of Runx2 mRNA is signiﬁcantly down-
regulated in 16.5 dpc Bmp2/4 DCKO femur (compare Fig. 2J with
Fig. 2U). On the other hand the mRNA expression of Bsp, a well
established late osteoblast marker, did not change signiﬁcantly upon
depletion of Bmp2 and Bmp4 (compare Fig. 2K with Fig. 2V) although
Fig. 1. Microarray meta-analysis. The overlap of the six different microarray datasets is displayed through a Venn diagram. The color codes for different microarray datasets
are provided. The number of genes present in four different microarray datasets is written in red while the number of genes present in three different microarray datasets is
written in blue. The identity of these genes is presented as a table in the ﬁgure as well as in Table S1.
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it was reduced to some extent. In Bmp2/4 DCKO mice, Bmp2 and
Bmp4 have been speciﬁcally depleted in the developing limb using
Prx1::Cre which recombines Bmp2 and Bmp4 loci as early as E9.5
(Bandyopadhyay et al., 2006). Thus in these mutant mice endochon-
dral ossiﬁcation began in the absence of Bmp2 and Bmp4 proteins
leaving open the possibility that the loss of expression of the seven
genes, namely Dpysl3, Gpr97, Klf10, Lox, Gja1, Dnpep and Osf2 was a
consequence of secondary changes arising out of abnormal endochon-
dral ossiﬁcation.
To further verify that the expression of these mRNAs in bone is
indeed regulated by Bmp2 and Bmp4 and is not an indirect
consequence of abnormal endochondral ossiﬁcation we used
another mouse mutant wherein we depleted Bmp2 and Bmp4
after endochondral ossiﬁcation has begun. For this purpose, we
used Bmp2/4 TiDCKO mouse strain where the Cre recombinase is
expressed as a fusion protein with a mutant form of estrogen
receptor under ROSA26 promoter (Badea et al., 2003; Soriano,
1999), allowing temporal control over depletion of Bmp2 and
Bmp4. Pregnant females were injected with tamoxifen at 14.5 dpc,
i.e., around the time endochondral ossiﬁcation begins. After
administration of a single dose of tamoxifen the level of BMP
signaling was signiﬁcantly reduced in the 16.5 dpc mutant femur,
as judged by p-Smad1/5/8 immunoreactivity (compare Fig. 3A
with Fig. 3L). Also the expression of Runx2 mRNA was signiﬁcantly
Fig. 2. Evaluating the dependence of transcription of putative target genes on BMP signaling in developing endochondral bones of 16.5 dpc wild-type and Bmp2/4 DCKO
mice. Immunoﬂuorescence with anti-p-Smad1/5/8 antibody (in red) in sections from (A) wild type femur and (L) Bmp2/4 DCKO femur. The sections are counterstained with
DAPI. RNA in situ hybridization analysis with Bmp target genes and bone markers on femur sections of (B–K) wild type and (M–V) Bmp2/4 DCKO mouse embryos. Scale bars:
100 μm.
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downregulated in the mutant femur upon tamoxifen administra-
tion (compare Fig. 3J with Fig. 3U). On the other hand, mRNA
expression of two known bone markers Col1a1 (compare Fig. 3B
with Fig. 3M) and Bsp (compare Fig. 3K with Fig. 3V) did not
change signiﬁcantly upon tamoxifen induced depletion of Bmp2
and Bmp4. We have also evaluated the extent of recombination of
the Bmp2 and Bmp4 loci at this time point. Our data demonstrates
that signiﬁcant level of recombination has occurred by 16.5 dpc
(Fig. S2A). Subsequently, in the 16.5 dpc femurs derived from
Bmp2/4 TiDCKO, we analyzed the expression of the seven genes
whose mRNA abundance in bone was downregulated in Bmp2/4
DCKO mice. Within 48 h of tamoxifen administration in Bmp2/4
TiDCKO mouse strain the mRNA expression of ﬁve of the seven
genes, namely Gpr97, Klf10, Lox, Gja1 and Dnpep (compare Fig. 3D–
H with Fig. 3O–S) was undetectable in the femur. However, the
expression of the remaining two genes Dpysl3 (compare Fig. 3C
with Fig. 3N) and Osf2 (compare Fig. 3I with Fig. 3T), although
signiﬁcantly downregulated, was still detectable. For higher mag-
niﬁcation images of the data presented in Fig. 3 please refer to the
supplementary Fig. S3.
Fig. 3. Evaluating the dependence of transcription of putative target genes on BMP signaling in developing endochondral bones of 16.5 dpc wild-type and Bmp2/4 TiDCKO
mice. Immunoﬂuorescence with anti-p-Smad1/5/8 antibody (in red) in sections from (A) wild type femur and (L) Bmp2/4 TiDCKO femur. The sections are counterstained with
DAPI. RNA in situ hybridization analysis with Bmp target genes and bone markers carried out on femur sections of (B–K) wild type and (M–V) Bmp2/4 TiDCKO mouse
embryos. Scale bars: 100 μm.
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Identiﬁcation of target genes whose expression is positively regulated
by BMP signaling in developing chick endochondral bones
Similar to the mouse embryo, endochondral ossiﬁcation in the
developing chick embryo is also critically dependent upon BMP
signaling (Duprez et al., 1996; Kawakami et al., 1996; Zou and
Niswander, 1996; Zou et al., 1997). Therefore, it is likely that BMP
signaling target genes in the developing endochondral bones may be
conserved between mouse and chicken. To test this possibility we
depleted Bmp2 and Bmp4 in the developing chicken limb bud using
a retrovirus (RCASBP(A)-gga-mirBmp2/mirBmp4) encoding miRNAs
targeting chicken Bmp2 and Bmp4mRNAs. Right hind limb buds
injected with high titer (1108 cfu/ml) RCASBP(A)-gga-mirBmp2/
mirBmp4 at HH18 were extensively infected with the virus at HH38
while the contra-lateral left limb was largely uninfected (compare
Fig. 4A with Fig. 4J). It should be noted that the viral backbone
carrying the knockdown constructs, also expresses EmGFP which
helps in demarcating the extent of infection (Smith et al., 2009a).
RCASBP(A)-gga-mirBmp2/mirBmp4 effectively reduced the levels of
Bmp2 and Bmp4 mRNAs in DF-1 cells as opposed to a control
microRNA construct RCASBP(A)-mirLacZ, which speciﬁcally targets
LacZ mRNA which did not reduce the levels of Bmp2 and Bmp4
mRNAs (Fig. S2B, compare Test lane with the Control lane). To test
the efﬁciency of RCASBP(A)-gga-mirBmp2/mirBmp4 in knocking
down Bmp2 and Bmp4 in vivo we used several lines of investigation.
First, upon infection of the developing chick eye at HH10 with
RCASBP(A)-gga-mirBmp2/mirBmp4, it phenocopied Gremlin misex-
pression, (Huillard et al., 2005) as was evident from the appearance
of dark streaks in the infected patches within the eye (data not
shown). It should be noted that Gremlin is an inhibitor of BMP
signaling. Second, as may be expected upon downregulation of BMP
signaling, the level of p-Smad1/5/8 immunoreactivity in infected
femurs at HH38 was signiﬁcantly downregulated in comparison to
the uninfected contra-lateral femurs (compare Fig. 4B with Fig. 4K).
Finally, the level of Runx2 mRNA in the RCASBP(A)-gga-mirBmp2/
mirBmp4 infected HH38 femur was signiﬁcantly downregulated in
comparison to the uninfected contra-lateral femur (compare Fig. 4I
with Fig. 4R). Among the seven genes which we have identiﬁed as
targets of BMP signaling in mouse endochondral bone the expression
of chick orthologs of ﬁve, namely Dpysl3, Gpr97, Klf10, Lox and Osf2
were downregulated signiﬁcantly in femurs infected with RCASBP
(A)-gga-mirBmp2/mirBmp4 virus (compare Fig. 4D–H with Fig. 4M–
Q). On the other hand the level of chick Col1a1mRNA expressionwas
not affected in the RCASBP(A)-gga-mirBmp2/mirBmp4 virus infected
femur (compare Fig. 4C with Fig. 4L). Despite several attempts, we
were unable to obtain good quality mRNA expression data for Gja1
and Dnpep in HH38 chick femurs with the probes that we used. Thus
it cannot be concluded whether these two genes are targets of BMP
signaling in chicken endochondral bones.
Gpr97, Klf10 and Lox are direct transcriptional targets of BMP
signaling in endochondral bone
We found that the transcription of Dpysl3, Gpr97, Lox, Osf2 and
Klf10 is dependent on BMP signaling in developing mouse as well
as chick endochondral bones. This led us to investigate whether
these ﬁve genes are direct targets of BMP signaling. For a gene to
be a direct target of BMP signaling it is expected that the
transcriptional cis-regulatory element of that gene would contain
one or more binding site(s) for p-Smad1/5/8. On activation of BMP
signaling p-Smad1/5/8 enters the nucleus independent of de novo
protein synthesis and activates transcription of a direct target.
Thus even in the presence of a protein synthesis inhibitor one
would expect the transcription of a direct target to be induced
upon activation of BMP signaling.
One method of demonstrating that a gene is a direct transcrip-
tion target of BMP signaling would be to carry out chromatin
immune-precipitation (ChIP) with the p-Smad1/5/8 antibody
followed by PCR with gene speciﬁc primers. However, despite
repeated attempts, ChIP with p-Smad1/5/8 antibody failed in our
hands. We thus adopted an alternative strategy. An established
method of demonstrating that a gene is a direct transcriptional
target of a signaling pathway or a transcription factor is to show
that its transcription is independent of nascent protein synthesis.
This is achieved through administration of cycloheximide, a
protein synthesis inhibitor (Sundlisaeter et al., 2010; Wade et al.,
2010). To investigate whether Dpysl3, Gpr97, Lox, Osf2 and Klf10 are
direct transcriptional targets of BMP signaling we pre-treated
C2C12 cells with cycloheximide prior to addition of Bmp2 protein.
Semi-quantitative RT-PCR analysis revealed that the abundance of
mRNAs of three of the ﬁve genes examined, namely Lox, Klf10 and
Gpr97 increased signiﬁcantly (compare Fig. 4S, lane 5 with lane 4)
after 3 h of Bmp2 treatment of C2C12 cells and this stimulation of
transcription was not blocked by cycloheximide (compare Fig. 4S,
lane 6 with lane 5). No signiﬁcant change in mRNA abundance was
observed between different experimental conditions at the zero
hour time point (compare Fig. 4S, lanes 1, 2 and 3) thus eliminat-
ing the possibility that expression of these genes is stimulated by
cycloheximide. In this experiment the abundance of the mRNAs of
the remaining two genes, namely Osf2 and Dpysl3 did not change
signiﬁcantly within three hours of exogenous Bmp2 protein
addition (data not shown).
Expression analysis of Dpysl3 mRNA
Dpysl3 has been relatively less studied in vertebrate model
systems. Recently its expression in the developing mouse brain has
been described (Niisato et al., 2012). However, the mRNA expression
pattern of mouse Dpysl3 in other developing structures, if any, has
not been reported. Towards this goal we conducted whole mount
RNA in situ hybridization analysis of Dpysl3 mRNA in 12.5 dpc and
14.5 dpc mouse embryos. We found that Dpysl3 mRNA is expressed
in several embryonic structures both at 12.5 dpc (Fig. 5A–F) and
14.5 dpc (Fig. 5G–O). In keeping with the earlier report, Dpysl3mRNA
is expressed in the spinal cord as well as in the developing brain at
12.5 dpc (Fig. 5B and Fig. 5C) and 14.5 dpc (Fig. 5G and Fig. 5H). In
addition to this, we detected Dpysl3 expression in the developing
eyes at 12.5 dpc (Fig. 5A) and more speciﬁcally in the retina and the
lens at 14.5 dpc (Fig. 5I). Dpysl3 expression is also detected in
developing external genitalia (Fig. 5D, 12.5 dpc and Fig. 5L–M,
14.5 dpc). Dpysl3 mRNA expression in developing limbs is barely
detectable at 12.5 dpc (Fig. 5E–F) while the expression is evident in
several developing limb structures at 14.5 dpc (Fig. 5J–K, dorsal view
and Fig. 5N–O, ventral view). It is likely that Dpysl3 is expressed in
tendinous structures including at tendon insertion points (Fig. 5N–O).
Interestingly, at 14.5 dpc Dpysl3 expression is visible at the tip of the
developing digits (arrow, Fig. 5K and Fig. 5O). This is reminiscent of a
region called phalanx forming region (PFR) earlier described as an
area of active BMP signaling (Suzuki et al., 2008).
Silencing Dpysl3 inhibits osteogenic differentiation of BMSCs
As mentioned above, Dpysl3 function is relatively unexplored. To
investigate the role of Dpysl3 in osteoblast differentiation and
mineralization activity, we decided to knockdown Dpysl3 in mouse
BMSC cells. Since it is difﬁcult to efﬁciently transfect BMSCs, we
decided to stably transfect mouse BMSC cells with a construct
expressing the chicken TV-A receptor thus enabling these avianized
BMSC cells to be infected by avian retroviruses for gene transduction
(Rhim et al., 1985). For knocking-down mouse Dpysl3 we screened
several miRNA constructs designed against mouse Dpysl3 through a
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dual luciferase sensor assay and selected the most efﬁcient one (Fig.
S2C). This was cloned in RCAS vector to generate RCASBP(A)-mmu-
mirDpysl3, which was used to infect the avianized mouse BMSCs.
BMSCs if cultured under osteogenic condition, form alkaline phos-
phatase (ALP), Alizarin Red and von Kossa positive bone nodules
(Bonewald et al., 2003). We observed that ALP activity as measured
by histochemical analysis was signiﬁcantly reduced in the avianized
mouse BMSC cells (TVA BMSCs) where Dpysl3 was silenced
compared to the control (compare Fig. 5P with Fig. 5S). For further
evaluation of the importance of Dpysl3 in bone mineralization,
avianized BMSCs infected with virus expressing miRNA against
Dpysl3 or against LacZ as a control were analyzed with Alizarin Red
(compare Fig. 5Q with Fig. 5T) and von Kossa staining (compare
Fig. 5R with Fig. 5U). Silencing Dpysl3 resulted in signiﬁcant reduc-
tion of Alizarin Red or von Kossa positive mineralized bone nodules
in TVA BMSCs. Moreover, quantitative colorimetric analysis of alka-
line phosphatase activity revealed a twofold reduction in the Dpysl3
silenced cells as compared to the control cells (Fig. 5V).
Dpysl3 regulates secretion from DF-1 cells
Bone is a tissue consisting of a large volume of extra-cellular
matrix. Thus it may be expected that a gene important for cell
secretion is important for bone morphogenesis. Dpysl3 has been
Fig. 4. Evaluating the dependence of transcription of putative target genes on BMP signaling in developing endochondral bones of uninfected and Bmp2/Bmp4 double
knockdown chick embryos at HH38. Fluorescent micrograph depicting the extent of virus infection in the hind limb of (J) RCASBP(A)-gga-mirBmp2/mirBmp4 virus infected
HH38 chick embryos (referred to as Bmp2/Bmp4 knockdown). (A) Uninfected control. Immunoﬂuorescence with anti-p-Smad1/5/8 antibody (in red) in femur sections of (B)
uninfected control and (K) Bmp2/4 knockdown HH38 chick embryos. The sections are counterstained with DAPI. RNA in situ hybridization analysis of Bmp target genes and
bone markers in femur sections of (C–I) uninfected control and (L–R) Bmp2/Bmp4 double knockdown chick embryos. (S) Semi-quantitative RT-PCR analysis to identify the
direct target genes of BMP signaling. Scale bars: 100 μm.
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reported to interact with the regulators of exocytosis and endocytosis
in worms (Quinn et al., 2003), therefore, we investigated whether
Dpysl3 may be involved in regulating secretion in vertebrates. Gaussia
luciferase (Gluc) is a secreted form of luciferase and is often used as a
reporter for secretion (Tannous, 2009). We transfected DF-1 cells with
pCSCW-Gluc-IRES-GFP, a plasmid expressing Gluc and pRmiR-gga-
mirDpysl3, a plasmid expressing a miRNA targeting chick Dpysl3. We
tested several miRNA constructs designed to knock-down chick Dpysl3
mRNA and used the most efﬁcient one as judged by sensor assay (see
Materials and methods section and Fig. S2D and I). We observed a
3 fold decrease in the secreted luciferase activity upon co-transfection
of pRmiR-gga-mirDpysl3 and pCSCW-Gluc-IRES-GFP as compared to
co-transfection of empty pRmiR vector and pCSCW-Gluc-IRES-GFP
(Fig. 5W). To ensure that this decrease in secretion is due to speciﬁc
downregulation of Dpysl3 expression we also co-transfected DF-1 cells
with pRmiR-mirLacZ, expressing miRNA targeting LacZ mRNA and
Fig. 5. Functional characterization of Dpysl3. Localization of mouse Dpysl3 mRNA by whole mount RNA in situ hybridization at (A–F) 12.5 dpc and (G–O) 14.5 dpc mouse
embryos. e, eye; te, telencephalon; sc, spinal cord; hb, hind brain; dn, diencephalon; fb, forebrain, t, tail; g, external genitalia; ﬂ, forelimb; hl, hindlimb; ob, olfactory bulb; l,
lens. (J and K) Dorsal view and (N and O) ventral view of forelimb and hindlimb, respectively. Arrows in K and O, indicates the expression of Dpysl3 mRNA at the digit tips.
(P–V) Effect of silencing Dpysl3 on osteoblast differentiation and mineralization. Avianized BMSCs infected with retrovirus expressing miRNA against mouse Dpysl3 gene.
Osteogenic differentiation of BMSCs was analyzed through alkaline phoshphatase histochemistry (P and S) and Alizarin Red (Q and T) and von Kossa staining (R and U). ALP
activity was also quantiﬁed using colorimetric analysis (V). nnn p value o0.001. (W) Depletion of Dpysl3 in DF-1 cells inhibits secretion which is quantiﬁed by measuring
Gaussia luciferase (Gluc) activity. n indicates p value smaller than 0.05 (po0.05), nnn indicates p value smaller than 0.001 (po0.001) and ♯ indicates that the difference is
non-signiﬁcant (pZ0.05). (mean 7SD; NZ3).
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pCSCW-Gluc-IRES-GFP. In this experiment the Gluc activity was
comparable to that of the DF-1 cells co-transfected with empty pRmiR
and pCSCW-Gluc-IRES-GFP. Further, we mis-expressed wild type rat
Dpysl3 in DF-1cells to rescue the loss of secretion of Gluc caused by
expression of miRNA targeting chick Dpysl3 (Fig. 5W). To demonstrate
that Dpysl3 functions downstream of BMP signaling to regulate
secretion we treated DF-1 cells with Bmp2 protein. This led to
stimulation of Gluc secretion by 1.5 fold which is signiﬁcantly reduced
if these cells also harbor pRmiR-gga-mirDpysl3. However, pRmiR-
mirLacZ does not signiﬁcantly change the level of secreted Gluc in
cells stimulated with Bmp2 protein (Fig. 5W).
In silico analysis of the ECRs upstream of the BMP signaling target
genes identiﬁed in this study
Our experimental data strongly indicates that Gpr97, Klf10 and
Lox are direct transcriptional targets of BMP signaling in develop-
ing long bones. It may therefore, be expected that the promoter–
enhancer regions of these genes will contain p-Smad1/5/8 binding
sites (Korchynskyi and ten Dijke, 2002). To investigate this, we ﬁrst
searched the GEO database (www.ncbi.nlm.nih.gov/geo). We came
across two relevant datasets, one reporting ChIP–Seq for p-Smad1/
5, GSE27661 and another reporting ChIP-chip for p-Smad1/5,
GSE18629. We found that Klf10 promoter enhancer region was
enriched in GSE27661, while the same for Gpr97 and Lox were not
enriched in either of the experiments. However, it should be noted
that neither of these datasets is derived from osteogenic cell lines
thus limiting the utility of these datasets for our analysis. We thus
used the mVista (Frazer et al., 2004) program to identify evolu-
tionary conserved regions (ECRs) in the 2 kb region upstream of
the transcription start sites (TSS) of these genes (Fig. 6A). The
p-Smad1/5/8 recognition sequence was detected within the ﬁrst
500 nucleotides upstream of the TSS of Gpr97, Klf10 and Lox. In
addition, we could also detect an Osterix (Osx) binding site (Yun-
Feng et al., 2010) upstream of Gpr97 TSS, a p-Smad2/3 recognition
sequence (Liu et al., 2003) upstream of Klf10 TSS and a Runx2
binding site (Zheng et al., 2003) upstream of Lox TSS. In the 2 kb
region upstream of the TSS of Gja1 and Osf2, genes which were not
found to be direct targets of BMP signaling in our cell culture
system based assay, we could not detect any p-Smad1/5/8 recog-
nition sequence. However, a conserved Runx2 binding site could be
located 770 bp upstream of Osf2 TSS. Upstream of Gja1 TSS we
detected two conserved Klf10 binding sites. A conserved Osx
binding site was also detected upstream of Gja1 TSS.
Even though, our cell culture based assay system suggested
that Dpysl3 is not a direct target of BMP signaling, a cluster of
several p-Smad1/5/8 and Runx2 binding sites were detected in the
500 bp upstream region of the TSS of Dpysl3, within ECRs (Fig. 6A).
To verify whether the predicted Runx2 binding sites and the
p-Smad1/5/8 recognition sequences upstream of Dpysl3 TSS are
functional, we constructed a dual luciferase reporter construct as
reported earlier (Yadav et al., 2012). In this construct, ﬁreﬂy
luciferase is cloned downstream of a putative promoter enhancer
region of Dpysl3 consisting of a 1497 nucleotide sequence (1422
to þ75 with respect to Dpysl3 TSS). This sequence of DNA contains
the evolutionarily conserved predicted Runx2 binding sites and
the p-Smad1/5/8 recognition sequences. In this dual luciferase
reporter construct, renilla luciferase is cloned downstream of SV40
promoter–enhancer sequence. The ﬁreﬂy luciferase activity in this
dual luciferase construct is not signiﬁcantly stimulated in presence
of Bmp2 or Runx2 alone. However, when both these factors were
present a relatively small but signiﬁcant stimulation of ﬁreﬂy
luciferase activity was observed (Fig. 6B). As another line of
investigation to examine the co-operative regulation of Dpysl3
transcription by Runx2 and BMP signaling we have also assessed
directly the abundance of Dpysl3 mRNA by quantitative RT-PCR of
total RNA isolated from C2C12 cells grown under different condi-
tions (Fig. 6C). In keeping with the dual-luciferase reporter assay,
described above, we observed signiﬁcant increase in Dpysl3 mRNA
abundance when cells transfected with Runx2 expressing plasmid
construct were also treated with Bmp protein. However, when
C2C12 cells were either treated with Bmp protein alone or were
transfected with the Runx2 expressing plasmid construct alone,
the abundance of Dpysl3 mRNA decreased as compared to the
same in untreated cells. The reason for this discrepancy in results
obtained through reporter assay and quantitative RT-PCR is not
immediately apparent. A likely explanation for this difference is
discussed below.
Discussion
Identiﬁcation of candidate BMP signaling target genes during
endochondral ossiﬁcation
The goal of this study was to identify genes that are expressed
in a BMP signaling dependent manner in developing endochondral
bones. One way of identifying such targets would be to compare
the transcriptome between wild type and BMP deﬁcient bones.
However, several technical problems would hinder the success of
such an approach such as the fact that in absence of BMP signaling
bone formation is severely affected (Bandyopadhyay et al., 2006)
and isolation of osteoblast cells from native tissue is technically
challenging, In absence of the ability to compare cells derived from
in vivo sources an alternative approach could be to compare the
transcriptome of osteogenic cells cultured in vitro in presence and
absence of BMP signaling. Using such transcriptomic proﬁling
many candidate BMP signaling target genes involved in osteogen-
esis have been reported in the literature. However, none of these
genes were demonstrated to be expressed in a BMP signaling
dependent manner during osteogenesis in vivo. Under these
circumstances we decided that instead of conducting our own
transcriptomic proﬁling we would utilize the existing datasets
available in the literature to identify such genes.
For this purpose, we chose six datasets for which experiments
were conducted under very similar conditions (Balint et al., 2003;
de Jong et al., 2004, 2002; Korchynskyi et al., 2003; Locklin et al.,
2001; Vaes et al., 2002). As reported in the result section, even
though these experiments were conducted under similar condi-
tions there was very little overlap between the gene sets predicted
to be targets of BMP signaling in these studies. Further, a closer
look at these microarray experiments also revealed that the trend
of stimulation of mRNA expression upon addition of Bmp protein
varied from one study to another i.e., there were differences in fold
change values of individual genes obtained from different micro-
array experiments. For example, Lumican,whose mRNA expression
was upregulated by more than thousand fold in the experiment
conducted by Vaes et al. (2002) was found to be one of the most
downregulated mRNAs in the experiment conducted by Balint
et al. (2003), suggesting that the fold change values observed in
microarray experiments may not be the best indicator of a gene
being a Bmp target in developing long bones. Therefore, we
decided to conduct a meta-analysis of these microarray datasets
to identify a set of genes which are reported in at least three out of
the six studies and thus have a high probability of being BMP
signaling target genes in vivo.
Using this approach we have identiﬁed 14 candidate BMP
signaling target genes in developing long bones. Further, using
two different knockout mouse models, we have demonstrated that
seven out of these 14 genes (Dpysl3, Gpr97, Klf10, Lox, Gja1, Dnpep
and Osf2) are targets of BMP signaling in developing mouse bones.
In addition, experiments conducted in chick embryos demonstrated
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Fig. 6. Transcriptional regulation of BMP signaling target genes. (A)mVista plot of 2 kb regions upstream of the TSS of Bmp target genes. Mouse genome has been used as the
base sequence for comparison with the rat and the human genomes. Peaks in mVista plot represent conserved regions. Conserved binding sites for p-Smad1/5/8, p-Smad2/3,
Runx2, Osx, Klf10 and Tcf/Lef are indicated in red. (B) and (C) Runx2 and p-SMAD1/5/8 co-operatively induce expression of Dpysl3. (B) Relative luciferase activity measured
through dual luciferase assay conducted with C2C12 cells transfected with the constructs as indicated. The ﬁreﬂy luciferase activity of each sample was normalized against
renilla luciferase activity. nnn indicates p value smaller than 0.001 (po0.001). (C) Abundance of mouse Dpysl3mRNA measured by quantitative RT-PCR. RNA samples isolated
from C2C12 cells cultured under indicated conditions were subjected to quantitative RT-PCR. The expression level of Dpysl3mRNA of each sample was normalized against β-
tubulin mRNA. nnn indicates p value smaller than 0.001 (po0.001).
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that ﬁve (Dpysl3, Gpr97, Lox, Osf2 and Klf10) of these seven genes are
conserved targets of BMP signaling in developing chick bones. We
demonstrated that Lox, Klf10, and Gpr97 are direct targets of BMP
signaling pathway since transcriptional activation of these genes
upon activation of BMP signaling does not require nascent protein
synthesis.
Validation of candidate BMP signaling target genes in vivo
Prior to this study many attempts have been made to uncover
targets of BMP signaling in developing bone. However, in none of
these studies the genes identiﬁed through in vitro approaches
were validated in vivo to be BMP signaling dependent. The
importance of such validation in vivo is particularly evident if we
consider the case of Hey1. As presented in Table S1and Fig S1, Hey1
was identiﬁed as a transcriptional target of BMP signaling in three
of the six studies used in the meta-analysis conducted by us. In
addition, Hey1 was also identiﬁed as a target of BMP signaling in
osteogenic cells in the study conducted by Zamurovic et al. (2004).
Interestingly, in the same study it was reported that knock-down
of Hey1 promoted mineralization indicating that Hey1 blocks
osteogenic differentiation. This is contrary to what would be
expected of a gene that is expressed in developing bone cells in
a BMP dependent manner. Another gene, Id3 was found to be
upregulated upon stimulation of osteogenic cells by BMP signaling
in the study reported by Zamurovic et al. (2004). Further, similar to
Hey1, Id3 was also found to be candidate target of BMP signaling
through our meta-analysis (Table S1and Fig S1). However, tran-
scription of neither Id3 nor Hey1 was found to be dependent on
BMP signaling when we carried out in vivo validation studies. This
underscores the importance of in vivo validation of candidate
target genes of a signaling pathway identiﬁed through in vitro
studies. In this study we have validated the candidate BMP
signaling target genes both in chick and mouse to ensure that
these are indeed authentic targets of BMP signaling in vivo in
developing bones.
Dpysl3 is likely to be an important regulator of osteoblast
differentiation
Among the Bmp target genes identiﬁed in this study Lox, Klf10,
Osf2, and Gja1 are already reported to be important for osteogen-
esis (Chaible et al., 2011; Pischon et al., 2009; Rios et al., 2005;
Subramaniam et al., 2005). Thus there is a distinct possibility that
the other three genes (Dpysl3, Gpr97, and Dnpep) identiﬁed in this
study are also likely to be important for endochondral ossiﬁcation.
Out of these three we chose to investigate the role of Dpysl3 in
bone morphogenesis presumably through its function as a reg-
ulator of cellular secretion. We speculated that Dpysl3 may play
such a role of based on our extrapolation of the reported roles of
Dpysl3 ortholog in worms (Quinn et al., 2003).
To investigate whether Dpysl3 may be important for differen-
tiation of osteoblast cells we used RNAi against mouse Dpysl3 in
avianized BMSCs in conjunction with three most commonly used
assays for osteoblast differentiation (Fig. 5P–V). In parallel, when
we knocked down chicken Dpysl3 in DF-1 cells using RNAi we
observed that Dpysl3 regulates secretion in these cells (Fig. 5W).
Taken together the results of these two lines of investigation
indicate that Dpysl3 is important for osteoblast differentiation
perhaps due to its role in secretion. However as we could not
conduct the secretion assays in osteoblasts we have not been able
to establish a direct link between the osteogenic differentiation
defect upon Dpysl3 depletion and a block in secretion. We
attempted to knockdown Dpysl3 in chicken embryos using the
RCAS retrovirus system to deliver a microRNA targeting Dpysl3
transcript (gga-mirDpysl3). Unfortunately, all attempts to recover
virus particles, encoding gga-mirDpysl3, from DF-1 cells failed. This
is probably due to the fact that Dpysl3 function is essential for
survival/proliferation of DF1 cells which are used to prepare the
gga-mirDpysl3 virus. It should be noted that Dpysl3 knockout
mouse has been generated and no overt bone phenotype has been
reported. One may interpret this to be contradictory to our data.
However, the fact that a bone phenotype has not been reported in
the Dpysl3 knockout mouse could be due to one or more of the
following reasons: (a) The phenotype is subtle and has not been
detected and (b) other paralogs of Dpysl3 function redundantly
with Dpysl3 in developing mouse bones. Nonetheless, our data
provides preliminary evidence that Dpysl3 may be involved in
osteogenesis through the regulation of cell secretion. This study
sets the stage for further investigation into the role of Dpysl3 in
osteogenesis.
Multiple signaling pathways collaborate with BMP signaling
to promote expression of bone speciﬁc genes required for different
aspects of osteogenesis
Based on our experimental data (Figs. 2 and 3), in silico analysis of
putative promoter–enhancer regions of the Bmp target genes and the
existing literature (summarized in Table S2), we propose a model of
osteogenesis (Fig. 7) integrating the roles of several signaling path-
ways, transcription factors and downstream effector genes in a
hierarchical manner. According to this model, inputs from several
signaling pathways are integrated at the level of expression of some of
the key transcriptional regulators of osteogenesis such as Klf10, Runx2
and Osx (Komori et al., 1997; Nakashima et al., 2002; Subramaniam
et al., 2005). We have identiﬁed both p-Smad2/3 and p-Smad1/5/8
binding sites in the 2 kb upstream region of Klf10 TSS. This taken
together with experimental observations [(Subramaniam et al., 1995)
and this work] suggests that Klf10 is regulated by both BMP and Tgf-β
signaling pathways. It has been demonstrated through in vitro studies
that both Runx2 and Osx are indirect targets of BMP signaling (Lee
et al., 2000, 2003a). In agreement with this, we could not detect any
p-Smad1/5/8 binding site upstream of Runx2 or Osx TSS. However, a
Klf10 binding site (Hawse et al., 2011) and a Tcf/Lef binding site (Gaur
et al., 2005) have been reported to be present upstream of Runx2 TSS.
Indeed it was demonstrated that Runx2 expression in osteogenic cell
line is regulated by Wnt signaling pathway (Gaur et al., 2005). Thus,
taken together, Runx2 expression is likely to be regulated by Wnt
signaling pathway as well as by BMP and Tgf-β signaling pathways
through Klf10. A Runx2 binding site has been reported upstream of Osx
TSS (Nishio et al., 2006) which perhaps explains the basis of indirect
regulation of Osx expression by BMP signaling. Finally, the down-
stream effector genes of osteogenesis, some of which have been
identiﬁed in this study as direct target genes of BMP signaling, are
also likely to be regulated by Wnt and Tgf-β signaling pathways either
directly or through the transcription factors such as Klf10, Runx2 and
Osx. It should be noted that presence of an evolutionarily conserved
transcription factor binding site in the promoter–enhancer region of a
gene may not be a strong indicator of actual transcriptional control of
the gene by the given transcription factor. Thus the model presented
here is speculative in nature and is primarily intended to indicate
possible directions for future experiments aimed at understanding
transcription control of osteogenesis.
In this study, we have used a dual luciferase based reporter assay
as well as quantitative RT-PCR assay to assess whether the predicted
p-Smad1/5/8 and Runx2 binding sites upstream of Dpysl3 TSS are
functional. Our study suggests that Dpysl3 transcription is indeed
cooperatively regulated by both p-Smad1/5/8 and Runx2. Thus at
least for Dpysl3 these two predicted transcription factor binding sites
seem to be functionally important. Surprisingly, as opposed to the
result obtained in dual luciferase reporter assay, in quantitative RT-
PCR assay the transcription of Dpysl3 was repressed in the presence
P. Prashar et al. / Developmental Biology 389 (2014) 192–207204
of either Bmp2 protein alone or the Runx2 cDNA construct alone. This
discrepancy can perhaps be explained by the fact that the luciferase
reporter assay used only a 1.5 kb fragment of Dpysl3 gene's putative
promoter–enhancer region, while the transcriptional output
observed in quantitative RT-PCR is likely to be inﬂuenced by genomic
elements present outside the fragment used in the luciferase
reporter assay.
In summary, we have identiﬁed seven BMP signaling target genes
in developing long bones, three of which appear to be direct
transcriptional targets of BMP signaling. These genes are likely to
be involved in various aspects of bone morphogenesis (Fig. 7). Osf2
and Lox are known to participate in ECM synthesis and modiﬁcation
(Maruhashi et al., 2010) while our data suggest that Dpysl3 partici-
pates in differentiation of osteoblasts through its role in cell secre-
tion. Gja1 is known to be important for cell–cell communication in
osteoblast and other cell types (Chung et al., 2006; Lecanda et al.,
1998). The in vivo functions of Dnpep and Gpr97 in osteogenesis are
yet to be deﬁned. We have proposed a speculative model of
transcriptional regulation of osteogenesis through integration of
various lines of evidence. This model may serve as a framework for
future investigations into the roles of different signaling pathways
and/or transcription factors in bone morphogenesis.
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